Harald Sommer
Munich, BY 80337, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Epithelial‑mesenchymal transition was identified as a potential marker for breast cancer aggressiveness using reverse transcription‑quantitative polymerase chain reaction.
Journal: Molecular medicine reports
Published: July 17, 2017
LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
Journal: Molecular oncology
Published: April 25, 2017
Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial.
Journal: Gynecologic oncology research and practice
Published: November 24, 2016
Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial.
Journal: Geburtshilfe und Frauenheilkunde
Published: May 31, 2016
Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer.
Journal: Breast cancer research and treatment
Published: March 14, 2015
Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology).
Journal: Cancer chemotherapy and pharmacology
Published: June 04, 2013
Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients.
Journal: Journal of cancer research and clinical oncology
Published: February 07, 2013
Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy.
Journal: Anticancer research
Published: October 13, 2012
Health-related quality of life during sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: a multicenter phase ii study of the North Eastern German Society of Gynecological Oncology.
Journal: Anticancer research
Published: September 21, 2012
Participation in the SUCCESS-A Trial Improves Intensity and Quality of Care for Patients with Primary Breast Cancer.
Journal: Geburtshilfe und Frauenheilkunde
Published: April 17, 2012
A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis.
Journal: Journal of cancer research and clinical oncology
Published: January 26, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026